Cash Flow from Operating Activities: A company's cash flows from operations.
Amplia Therapeutics Ltd. (INNMF) had Cash Flow from Operating Activities of $-5.78M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$21.86M |
|
-- |
|
$5.32M |
|
$27.42M |
|
$1.10M |
|
$0.17M |
|
$0.20M |
|
$1.30M |
|
$26.11M |
|
$20.86M |
|
$26.11M |
|
-- |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-5.78M |
$-0.06M |
|
$17.16M |
|
$7.19M |
|
$18.43M |
|
$11.24M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|